michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
This is Frank. So the -- I mean, we're thinking about it in terms of delivering the leverage on the business for the -- and the price/cost in isolation, obviously, on the way up, it's not necessarily margin accretive, OK? So we're just looking at it holistically in terms of delivering 30%-plus operating leverage for the business for the year. The price/cost, given the way it has rolled and will roll through, very lumpy, very distortive within the quarters, so we're just very focused on getting to that goal for the year, delivering up margins and -- for the enterprise and delivering the operating leverage.
Regarding the restructuring, I'll take a quick stab and then either Ram or Lal can come in. And your question was around continued restructuring spend. So as we go through this, we identify additional opportunities in both businesses. some of it is footprint consolidation. I mean the cost reduction in March -- it was kind of a never-ending March. We identified obviously very significant opportunities that we've executed on for the most part when we talked about driving to previous peak margins.
But there's more to do in a complex business. We're continually trying to improve the cost position. And frankly, much of what we do in terms of capex and restructuring over the next couple of years will be around capacity expansion for the growth that we expect to see in both businesses. So we may be engaged in some restructuring that's a little bit higher than our historical levels. But it's all around continuing -- improving the cost position and putting in the capacity in the right places.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for the question and the additional data. I'd like to -- maybe a broader question on, you know, given the recent impressive protease inhibitor data. I just want to hear your update thoughts from targeting the RNA polymerase directly versus the protease. You know, we, I guess, previously were thinking the correlation between HCV and HIV and other more chronic diseases would suggest the RNA polymerase was the correct targets for, you know, minimizing resistance.
But is that so the case? And can we really extrapolate those diseases with the SARS-CoV-2 and COVID-19?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's much better, Jernej, actually, when you're close to the mic.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's continued -- its the volume coming back, so I think that's first and foremost. We see business like Fluke coming back that's a high margin business. You saw 280 basis points of core OMX and at IOS, it's a strength of the SaaS growth in the software businesses, but you know it was across the board. So IOS certainly led the pack as you know on a quarterly basis, there's always one segment that leads the pack a little bit more than the others, but I think what we saw with the breadth of OMX and I think as we sit here looking into 2021, the 50 basis points that we grew OMX despite all the issues in 2020 is this tremendous confidence that we can continue to do that in '21.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Jenna. We're going to Stuart.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. As I said, I certainly don't see downside to aggregate pricing next year. And if we're looking at the film material that's gone out this year in the East, in particular, year to date. Phil, this will give you a great sense of it. It's been about 900,000 tons. And part of what's happened here over the last, during the last quarter as well is, we started shipping some stone on a large NCDOT project that's here in the Raleigh area that was bid about two years ago. So again, those are just some of the more optical issues. Something that I think is worth always keeping in mind, Phil, is when base is going in a year like this, what you know is going to happen is the clean stone is going to go behind that because at some point, you're going to put either asphalt or concrete on top of the clean stone. And we actually see those clean stone prices moving in a very attractive way.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So Mark, you're right. The mere fact that the court systems have shut down may or may not be the total driver there. And that's why we kind of remain cautious. If we don't know what all the drivers are. We do believe that there are probably plaintiff lawyers that are sitting on lawsuits and waiting to file them until the court systems open back up, just because they don't necessarily want to start off in a position where you're negotiating to settle without the prospect of being able to litigate. And so we think there is some impact. We don't know exactly what that impact is, and that's why we remain cautious. Mike, I don't know if you'd add anything to that?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. I think you've got it pegged right. It's seasonality in the first quarter. And there is -- we'll be able to grow from there.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. On the enterprise, we're actually -- we're -- we have traction now in the enterprise segment. But the revenue is still fairly small. Obviously, that business scales as we grow the business. So we already have some really positive traction right now. That will grow as we go into '22, but I don't anticipate that to become material until we get into 2023. And so we'll continue to grow that business scale out. We can grow that while they're building the network because it's not constrained by geography. And so we can actually -- and we are pursuing opportunities that aren't limited by the geographies and footprint we're deploying. But as we build that footprint out, then it expands the market opportunity for us. So we'll see that sort of begin to pick up as we go through '22, but really not having a material impact until we get into '23. So that's kind of where we see the enterprise.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hard to put a number on that, but I think what we said all along was that we expected and anticipated that this year would see a meaningful recovery toward normalcy, with that normalcy being achieved in 2022. You know, I think we saw essentially very much along those lines, right? We've seen a return to normalcy in a number of places, although I think still not all the way there, and then certain markets that are -- segments that are meaningfully behind. And those will hopefully have a chance to be significantly more normal next year as well. So still a lot of upside opportunity.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Sure. Obviously, people join companies and people leave companies. I can't get into the details of our decision to part ways with Dr. Kaba. But I can tell you that we are very, very confident in our medical messaging and positioning now. We think the changes that we've made over the past couple of years, focusing on the need to treat that broader information, looking at the potential of the disease and that underlying information creating damage in the neuro fiber layers is pretty critical to differentiating the value of ILUVIEN. The great thing is the entire company is sort of unified around that story and that strategy. And so, we will continue on pushing that, and we will certainly search for a replacement for Dr. Kaba.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Sure, David. I would say first of all, you kind of got to ground yourself to a year ago in China where the pandemic started during the first quarter. So clearly, the growth rate in China year-over-year comparatives is higher than it is for the rest of the world because it was such a low point last year in the first quarter. So clearly, China is going to show in a percentage standpoint, a much higher growth rate in our first quarter versus last year than the other regions of the world because of that.
However, if you kind of normalize that, right, and say, what's it look like through the course of the year. While you're going to get these opposite impact in the second quarter, where so much of the rest of the world got impacted, and China was starting to turn back on by second quarter that you'll see that maybe the rest of the world is growing faster than China in the second quarter when you do the comparatives on it, but that's really all to do with history on what was taking place last year. We continue to see ongoing strong order rates and demand in all segments of the business out of China and Asia in general. So it continues to be quite healthy. From a double booking standpoint, yes, we see double bookings coming out of Asia, but we also see them kind of globally.
I think it probably gets elevated from the standpoint in Asia, in general, a lot of contract manufacturing is going on out in Asia. So therefore, a lot of the bookings that are flowing through contract manufacturing are showing up there. But I'm not sure we would say that China specifically is driving the really strong orders or evidence of double booking specifically.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Sean, it's a good question. Obviously, we're monitoring it. We have long-term great relationships with all our vendors. We work closely with them. We'll continue to do so. It's really up and down the pinata [Phonetic] where it is, so far equipments all been good, no problems, steel and copper, you probably heard it, I'm sure 20 times now. Pricing up but there is availability. But nothing that's really impacting us at the moment. We are functioning our job sites go in and nothing has been delayed so far. So we'll continue to monitor it, but it's out there. But thank God we have the relationships that we do have.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No, I think, he said, thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. So I think we haven't segmented the orders in such a way that I can give you exact numbers on how much are large projects that have a certain flow in terms of revenue and blanket orders, but it was significant. I'd say the mix of orders that came in, in the first quarter was more biased toward the longer lead time types of orders than we would normally get, which is encouraging given the longer cycle nature of those orders. So -- but I don't have an exact breakdown for you, Nathan, on that.
What was the second -- could you repeat the second part of your question?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
OK. Thanks, Pearce

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Bill, it's interesting -- what people have to realize and it's not unique to Baltimore, is that CBDs migrate. They expand, they contract, and they creep over time. Great example is where we are in Atlanta, now at West Midtown. 10 years ago, West Midtown wasn't a market. So in Baltimore, the way we're looking at it is, it's a migration of a mile or so, not an indictment on the CBD itself, but that these things will go where they're going to go. We developed a number of buildings on the waterfront in Georgetown. And the waterfront in Georgetown and Downtown DC, as you may recall was a wasteland 20 years ago. And now it's a hotbed. So, I think people need to pull back and not be too concerned about which blocks are doing what. But the fact that a company like T. Rowe Price born and raised in Baltimore stays in Baltimore is a huge win for the city.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, thank you very much. Like everybody else, just extend my thanks and best wishes to Kay as she moves on. And thanks for all your input and time over the years. I wanted to ask a couple of follow-up questions. First, you highlighted that tourism is coming back, but there's still some more to go there. But also like normal day-to-day life is also returning. Any characterization you could give us of like how much tourism has recovered? Are we back to kind of 70% to 80% of the -- what you would suspect is tourist-related spend? Or just any metrics around that versus day-to-day? Just trying to gauge where you guys are seeing benefit right now.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm hesitant to say because when we do say it, I want to make sure that we've gone deep on the data assessment of that. Chris Nelson and Justin Keppy and the team are looking at that and it really is critical not only so we can answer your question more specifically, but for our planning purposes, we actually -- we came into this year underestimating our demand, and that's driving a lot of -- we're doing a lot of hiring that we didn't anticipate doing.
So we need to get as precise on that answer for you and for ourselves as possible, but I'm hesitant to throw out a number on this call until we've gone deeper on it. But we will be coming back to you on that shortly.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, guys. This is Joe Meares on for Terry. You've owned Brandfolder for a bit now. I'm just wondering -- circling back to the question about how M&A has progressed and how that's helping you.
How are you thinking about M&A going forward with your appetite? How's the pipeline? And how do you think about valuations right now?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
The cohorts we'll have middle of the year will be the two lower dose cohorts. So we still have the top dose in CF patients to go.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm sorry.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you very much, Don and Jon. Best to both of you. Don, I have a question for you. Could you talk about one or two actions that you've taken in this tenure that Jon and Brian are going to be talking about two or three years from now, that will make -- be part of why the growth rate or the margin or the cash conversion looks the way it does?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
The team is focused on getting us back to those double-digits levels, absolutely. It will take time, but unequivocally we believe that that is absolutely an achievable target for us and the team.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's a very good question, Jeff and we've thought about that one. And you're right. With aged backlog, you got to be very, very careful because if you don't go back and revisit your backlog and reprice it, then you're going to have a problem. And I can tell you that's a very active exercise we're doing because as you can imagine, I mean, we -- just to quote some figures.
I mean, steel is up 198% year over year, nickel 25%, copper 46%, aluminum 66%. I mean, these are fairly substantial increases. So what we've been doing in more or less all of our businesses and particularly long cycle ones is trying to go back and reprice some of our backlog. You kind of almost have to do that because -- and not to even mention labor inflation, which we're also seeing.
So it's part of our playbook, part of our exercise and exactly what we've been trying to do.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Jackie, that's a super interesting question. And I would say that our top priority remains to get Rosemont through the Ninth Circuit Court of Appeals. That is priority number one. But the Copper World discovery certainly does provide us with a very, very interesting, either alternative or add-on. And so, we've done, as you know, a lot of work on Copper World. We've identified four separate deposits with potential for several more in a strike length of some 5 kilometers. Some of the drill results that I mentioned are pretty outstanding.
And the most interesting feature is that mineralization starts from surface. So, clearly it's something that you can get into right away. But we have to complete the assay program that's currently underway, so that we can develop that inferred resource by the end of the year, so that we can in turn complete a PEA early next year. And that really will inform us with respect to sort of how the one stacks up against the other. But in any case, I'd like to come back to my initial comment that Rosemont does remain a priority for us, but Copper World presents a super existing potential alternative or addition.

    Prediction (one of UP, DOWN, SAME): SAME